Mountain View, CA, United States of America

Neil C Gorley

This inventor holds 1 USPTO granted patent. Top assignee: Incyte Genomics, Inc.. Active years: 2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Neil C Gorley. Retrieved from https://idiyas.com/inventor/neil-c-gorley

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2002

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Neil C. Gorley: Innovator in Human Phospholipase A2 Protein

Introduction

Neil C. Gorley is a notable inventor based in Mountain View, CA (US). He has made significant contributions to the field of biotechnology, particularly in the development of human phospholipase A2 protein. His work has implications for various medical treatments and advancements.

Latest Patents

Neil C. Gorley holds 1 patent for his invention related to human phospholipase A2 protein. This invention provides a human phospholipase A2 protein, known as PHPLA2, along with polynucleotides that identify and encode PHPLA2. Additionally, the invention includes expression vectors, host cells, agonists, antibodies, and antagonists. It also outlines methods for treating disorders associated with the expression of PHPLA2.

Career Highlights

Neil is currently associated with Incyte Genomics, Inc., where he continues to work on innovative solutions in the biotechnology sector. His expertise and research have positioned him as a valuable asset in his field.

Collaborations

Neil has collaborated with notable colleagues, including Phillip R. Hawkins and Olga Bandman, contributing to advancements in their shared areas of research.

Conclusion

Neil C. Gorley's work in the development of human phospholipase A2 protein showcases his innovative spirit and dedication to improving medical treatments. His contributions are significant in the realm of biotechnology and continue to influence the industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…